newsfilter
← Latest News
PR Newswire·

DW Healthcare Partners Announces Sale of LKC Technologies to AMETEK, Inc.

  • DW Healthcare Partners announces the sale of LKC Technologies to AMETEK, Inc. (NYSE: AME).
  • LKC Technologies, a portfolio company of DW Healthcare Partners' Founders Fund, specializes in visual electrophysiology & has operated for over 35 years.
  • The company's flagship product is the handheld, non-invasive RETeval device used for diagnosing retinal & optic nerve diseases.
  • CEO Dina Dubey thanked DW Healthcare Partners for their support & significant contributions to the company's growth over the last three years.
  • DW Healthcare Partners Managing Director Gabe Becher highlighted the partnership's success in scaling operations & raising awareness of functional retinal testing.
  • William Blair served as the exclusive financial advisor to LKC Technologies during the transaction.
  • DW Healthcare Partners manages six funds with over $2.7 billion in assets under management as of December 31, 2025.